Home > Research Areas > Metabolic Disorder > Obesity
Cat. No. Product name CAS No.
DC8160 ZGN-440(Beloranib)

Beloranib is being studied as a first-in-class obesity therapy that demonstrates a unique mechanism of action through methionine aminopeptidase 2 (MetAP2 ) inhibition.

251111-30-5
DC9414 DGAT-1 inhibitor 2

DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents.

942999-61-3
DC12255 MLN-4760

MLN-4760 is a potent and selective human ACE2 inhibitor (IC50, 0.44 nM), with excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypeptidase A (CPDA; IC50, 27 μM).

305335-31-3
DC7109 Otenabant (CP-945598 free base)

Otenabant (CP945598) is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM.

686344-29-6
DC7495 SB-334867 HCl

SB-334867 is a selective non-peptide orexin OX1 receptor antagonist with a pKb value of 7.2.

249889-64-3
DC8419 SB-334867

SB-334867 is a selective orexin-1 (OX1) receptor antagonist.

792173-99-0
DC10323 Setmelanotide

Setmelanotide (RM-493;BIM-22493;IRC-022493) is a melanocortin 4 receptor (MC4R) agonist with an EC50 of 0.27 nM for human MC4R.

920014-72-8
DC4158 Tranabant (MK-0364)

Taranabant is a highly selective cannabinoid-1 (CB1) receptor inverse agonist.

701977-09-5
DC1076 Otenabant(CP945598.HCl)

CP-945598 HCl is a potent and selective cannabinoid type 1 receptor antagonist with Ki of 0.7 nM.

686347-12-6
Page 1 / Total 1 FirstPrevNextLastGoto